Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-02-15

Clinical Trial Update: Effect of the Nasal Gel "Nascum®-Plus" on Allergic Symptoms [NA]

View source ↗

Summary

The study reports on the completed clinical trial evaluating the nasal gel Nascum®-Plus for reducing symptoms of seasonal allergic rhinitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nascum®-Plus

Snippet

Sponsor: Fraunhofer-Institute of Toxicology and Experimental Medicine | Conditions: Rhinitis, Allergic, Seasonal | NA | Status: COMPLETED